Regenerate. Repair. Restore.

Stem Cells Therapy for Cranial Neuropathy

Cranial neuropathy is a type of focal neuropathy that is a condition that damages nerves in the brain and brainstem.

Cranial neuropathy occurs when one or more of the twelve nerves that exit the brain are damaged. The symptoms of cranial neuropathy vary according to which nerve is affected.

Treatment at the Stem Cells Transplant Institute could help improve the symptoms of cranial neuropathy, including:

Sharp, jabbing or throbbing pain
Drooping of the facial muscle
Tingling
Feeling of numbness
Loss of vision
Double vision

Abnormal movement of the eye
Blurred vision
Increased pupil size
Droopy eyelid
Weak or paralyzed muscles
Touch-sensitive skin

What is cranial neuropathy?

Cranial neuropathy occurs when one or more of the twelve nerves that exit the brain, or brain stem, are damaged.

Types of cranial neuropathies include:

Bell’s palsy: This condition occurs when the facial nerve, or seventh cranial nerve, is affected.
Microvascular cranial nerve palsy: This condition affects the nerves in the eye. It is most common in people who have diabetes and in those who have high blood pressure.
Third nerve palsy: This condition affects the third cranial nerve. This nerve helps manage a muscle that controls eye movement.
Fourth nerve palsy: This is also called superior oblique palsy. It affects the superior oblique muscle, which helps you converge your eyes (to look at the tip of your nose).
Sixth nerve palsy: This is also called cranial nerve VI or abducens palsy. It affects the sixth cranial nerve, which also helps control eye movement.
Multiple cranial neuropathies: Several different cranial nerves are affected

Possible causes of cranial neuropathy include:

Diabetes
High blood pressure
Migraine headaches
Infections
Inherited disorders
Tumor
Trauma
Virus

What do we know about cranial neuropathy?

Medicines can be used to treat an infection, reduce swelling in or around a nerve, or alleviate pain caused by neuropathy. Surgery may be beneficial in some cases. Other times, the nerve damage is irreversible and cannot be treated or repaired.

How can stem cell therapy improve the symptoms of cranial neuropathy?

Mesenchymal stem cells produce;

Proteins that support the growth and survival of neurons
Angiogenic factors that are essential for the healing, growth, development, and maintenance of blood vessels
Immunomodulatory substances that can reverse the damage to the nerves

What is the treatment protocol for cranial neuropathy at the Stem Cells Transplant Institute?

The Stem Cells Transplant Institute recommends the use of hUC-MSCs for the treatment of neuropathy.

Treatment includes:

Mesenchymal stem cells derived from human umbilical cord tissue.
Antioxidant therapy with vitamin C and glutathione.
Ozone therapy.
Platelet-rich plasma therapy (PRP).

umbilical cord donations

Intravenus Administration

How Are the Stem Cells Collected?

Our clinic focuses on obtaining healthy stem cells exclusively from umbilical cord blood donors. We collect the placenta once the baby is born, with the parent’s informed consent. Additionally, we follow strict ethical guidelines and collect stem cells from reliable and reputable sources.

How Are the Stem Cells Administered?

Our nursing staff administers the stem cells through an intravenous and intra-pulmonary route. For the most effective outcomes, intravenous administration is preferred.

About the Stem Cells Transplant Institute

Our clinic is located in Costa Rica, which is one of the most popular medical tourism destinations for stem cell therapy. At the Stem Cells Transplant Institute, we have a skilled team of doctors and medical professionals who collect and administer stem cells to treat autism and other conditions. Every patient receives the most cost-effective and top-notch care from our dedicated team.

Scientific References:

Cell Death Discovery (2016) 2, e16055; doi:10.1038/cddiscovery.2016.55; published online 11 July 2016 Mesenchymal stem cells to treat diabetic neuropathy: a long and strenuous way from bench to the clinic JY Zhou
Han, JW et al., Bone Marrow-Derived Mesenchymal Stem Cells Improve Diabetic Neuropathy by Direct Modulation of Both Angiogenesis and Myelination in Peripheral Nerves. Cell transplant.2016;25(2):313-26. doi: 10.3727/096368915X688209. Epub 2015 May 13
Vickers RE et al., A preliminary report on stem cell therapy for neuropathic pain in humans. J Pain Res. 2014; 7: 255–263. Published online 2014 May 8.